Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553878-17-000055
Filing Date
2017-11-01
Accepted
2017-11-01 17:33:14
Documents
1
Period of Report
2017-10-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 13189
  Complete submission text file 0001553878-17-000055.txt   14571
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02139
Business Address
Vaishnaw Akshay (Reporting) CIK: 0001458494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 171170058